Dr. Martens plc (LON:DOCS - Get Free Report)'s stock price traded up 18% during mid-day trading on Thursday . The stock traded as high as GBX 74.30 ($1.01) and last traded at GBX 70.75 ($0.96). 6,163,005 shares changed hands during trading, an increase of 176% from the average session volume of 2,233,193 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada dropped their target price on Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.
View Our Latest Stock Report on DOCS
Dr. Martens Trading Up 8.7%
The stock has a market cap of £795.54 million, a PE ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11. The firm has a 50-day simple moving average of GBX 55.34 and a 200-day simple moving average of GBX 62.91. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.
Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities analysts forecast that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The company also recently declared a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's payout ratio is currently 42.53%.
Insider Transactions at Dr. Martens
In other news, insider Giles Wilson purchased 32,640 shares of the firm's stock in a transaction dated Tuesday, March 25th. The shares were purchased at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,857.07). Over the last quarter, insiders have bought 33,206 shares of company stock valued at $1,792,771. 4.36% of the stock is currently owned by company insiders.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Further Reading
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
